Concepts (176)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Eyelid Neoplasms | 2 | 2020 | 28 | 0.960 |
Why?
|
| Hamartoma Syndrome, Multiple | 1 | 2020 | 20 | 0.690 |
Why?
|
| Orbital Neoplasms | 4 | 2023 | 49 | 0.440 |
Why?
|
| Orbital Diseases | 4 | 2021 | 72 | 0.360 |
Why?
|
| Carcinoma, Neuroendocrine | 1 | 2008 | 38 | 0.280 |
Why?
|
| Hamartoma | 2 | 2007 | 52 | 0.280 |
Why?
|
| Paranasal Sinus Diseases | 1 | 2007 | 15 | 0.270 |
Why?
|
| Cartilage | 1 | 2007 | 51 | 0.270 |
Why?
|
| Chondrocytes | 1 | 2007 | 51 | 0.260 |
Why?
|
| Mesoderm | 1 | 2007 | 113 | 0.260 |
Why?
|
| Calcinosis | 1 | 2007 | 189 | 0.240 |
Why?
|
| Optic Nerve Diseases | 2 | 2023 | 86 | 0.240 |
Why?
|
| Orbital Implants | 2 | 2021 | 12 | 0.230 |
Why?
|
| Cornea | 5 | 2018 | 595 | 0.230 |
Why?
|
| Fasciitis | 1 | 2024 | 20 | 0.220 |
Why?
|
| Lacrimal Duct Obstruction | 1 | 2024 | 17 | 0.220 |
Why?
|
| Nasolacrimal Duct | 1 | 2024 | 20 | 0.220 |
Why?
|
| Canaliculitis | 1 | 2023 | 3 | 0.220 |
Why?
|
| Eye Infections, Fungal | 3 | 2018 | 73 | 0.210 |
Why?
|
| Lymphoma, B-Cell, Marginal Zone | 1 | 2023 | 53 | 0.210 |
Why?
|
| Candidiasis | 3 | 2018 | 138 | 0.200 |
Why?
|
| Dermoid Cyst | 1 | 2023 | 34 | 0.200 |
Why?
|
| Cysts | 1 | 2023 | 97 | 0.200 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 2023 | 168 | 0.190 |
Why?
|
| Ophthalmologic Surgical Procedures | 2 | 2018 | 78 | 0.170 |
Why?
|
| Keratitis | 2 | 2018 | 107 | 0.170 |
Why?
|
| Orbital Fractures | 1 | 2021 | 33 | 0.170 |
Why?
|
| Choroid Neoplasms | 1 | 1999 | 18 | 0.150 |
Why?
|
| Nevus, Pigmented | 1 | 1999 | 31 | 0.150 |
Why?
|
| Systemic Vasculitis | 1 | 2018 | 2 | 0.150 |
Why?
|
| Hemangioblastoma | 1 | 2018 | 12 | 0.150 |
Why?
|
| Candida parapsilosis | 1 | 2018 | 2 | 0.140 |
Why?
|
| Stomach Neoplasms | 1 | 2023 | 496 | 0.140 |
Why?
|
| Exophthalmos | 1 | 2018 | 31 | 0.140 |
Why?
|
| Melanoma | 2 | 2009 | 953 | 0.130 |
Why?
|
| Neuroendocrine Tumors | 1 | 2018 | 59 | 0.130 |
Why?
|
| Orbit | 1 | 2018 | 84 | 0.130 |
Why?
|
| Diagnosis, Differential | 4 | 2023 | 1964 | 0.130 |
Why?
|
| Retinal Neoplasms | 1 | 2018 | 102 | 0.130 |
Why?
|
| Neoplasms, Second Primary | 1 | 1999 | 150 | 0.130 |
Why?
|
| Sclera | 2 | 2009 | 45 | 0.120 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2018 | 295 | 0.110 |
Why?
|
| Conjunctival Neoplasms | 1 | 2013 | 15 | 0.100 |
Why?
|
| Eye Neoplasms | 1 | 2013 | 46 | 0.100 |
Why?
|
| Retinal Detachment | 1 | 2013 | 71 | 0.100 |
Why?
|
| Humans | 26 | 2024 | 133181 | 0.100 |
Why?
|
| Laryngeal Neoplasms | 1 | 2013 | 94 | 0.100 |
Why?
|
| Orbital Myositis | 1 | 2012 | 4 | 0.100 |
Why?
|
| Granuloma, Foreign-Body | 1 | 2012 | 7 | 0.100 |
Why?
|
| Uveal Neoplasms | 2 | 2013 | 56 | 0.100 |
Why?
|
| Silicon Dioxide | 1 | 2012 | 31 | 0.100 |
Why?
|
| Tomography, X-Ray Computed | 6 | 2023 | 2190 | 0.090 |
Why?
|
| Female | 21 | 2024 | 71395 | 0.090 |
Why?
|
| Ileal Neoplasms | 1 | 1990 | 7 | 0.080 |
Why?
|
| Eye Enucleation | 4 | 2013 | 45 | 0.080 |
Why?
|
| Visual Acuity | 5 | 2018 | 709 | 0.080 |
Why?
|
| Carcinoid Tumor | 1 | 1990 | 24 | 0.080 |
Why?
|
| Eyelid Diseases | 2 | 2023 | 55 | 0.080 |
Why?
|
| Endothelium, Corneal | 2 | 1989 | 28 | 0.080 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2018 | 874 | 0.080 |
Why?
|
| Gold Radioisotopes | 1 | 2009 | 2 | 0.080 |
Why?
|
| Descemet Membrane | 1 | 1989 | 10 | 0.080 |
Why?
|
| Candida albicans | 2 | 2000 | 89 | 0.080 |
Why?
|
| Aged | 8 | 2023 | 21448 | 0.070 |
Why?
|
| Brachytherapy | 1 | 2009 | 93 | 0.070 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2013 | 782 | 0.070 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2023 | 3863 | 0.070 |
Why?
|
| Radiation Injuries | 1 | 2009 | 161 | 0.070 |
Why?
|
| Strabismus | 1 | 2007 | 54 | 0.060 |
Why?
|
| Blepharoptosis | 1 | 2007 | 63 | 0.060 |
Why?
|
| Triamcinolone | 2 | 2012 | 15 | 0.060 |
Why?
|
| Ovarian Neoplasms | 1 | 1990 | 467 | 0.060 |
Why?
|
| Glucocorticoids | 3 | 2012 | 399 | 0.060 |
Why?
|
| Eyelids | 2 | 2023 | 96 | 0.060 |
Why?
|
| Erdheim-Chester Disease | 1 | 2004 | 28 | 0.060 |
Why?
|
| Male | 15 | 2024 | 65478 | 0.060 |
Why?
|
| Fusobacterium Infections | 1 | 2004 | 14 | 0.050 |
Why?
|
| Cavernous Sinus Thrombosis | 1 | 2004 | 8 | 0.050 |
Why?
|
| Thrombophlebitis | 1 | 2004 | 20 | 0.050 |
Why?
|
| Dacryocystorhinostomy | 1 | 2024 | 18 | 0.050 |
Why?
|
| Fusobacterium nucleatum | 1 | 2004 | 25 | 0.050 |
Why?
|
| Neoplasm Proteins | 1 | 2008 | 712 | 0.050 |
Why?
|
| Dyspnea | 1 | 2004 | 160 | 0.050 |
Why?
|
| Durapatite | 1 | 2003 | 14 | 0.050 |
Why?
|
| Blindness | 1 | 2004 | 76 | 0.050 |
Why?
|
| Eye Infections, Bacterial | 1 | 2004 | 86 | 0.050 |
Why?
|
| Coated Materials, Biocompatible | 1 | 2003 | 38 | 0.050 |
Why?
|
| Eye Diseases | 1 | 2004 | 118 | 0.050 |
Why?
|
| Twins, Monozygotic | 1 | 2023 | 128 | 0.050 |
Why?
|
| Pericardium | 1 | 2003 | 86 | 0.050 |
Why?
|
| Middle Aged | 11 | 2018 | 28912 | 0.050 |
Why?
|
| Nose | 1 | 2023 | 105 | 0.050 |
Why?
|
| Positron-Emission Tomography | 1 | 2023 | 312 | 0.050 |
Why?
|
| Diabetes Mellitus | 1 | 1989 | 936 | 0.040 |
Why?
|
| Fundus Oculi | 2 | 2018 | 64 | 0.040 |
Why?
|
| Corneal Ulcer | 1 | 2000 | 54 | 0.040 |
Why?
|
| Biomarkers, Tumor | 1 | 2008 | 1692 | 0.040 |
Why?
|
| Prostheses and Implants | 1 | 2021 | 153 | 0.040 |
Why?
|
| Fluorescein Angiography | 2 | 2018 | 154 | 0.040 |
Why?
|
| Liver Neoplasms | 1 | 1990 | 1404 | 0.040 |
Why?
|
| Microscopy, Electron, Scanning Transmission | 1 | 1999 | 6 | 0.040 |
Why?
|
| Contact Lenses | 1 | 1999 | 42 | 0.040 |
Why?
|
| Chronic Disease | 1 | 2023 | 1236 | 0.040 |
Why?
|
| Melanocytes | 1 | 1999 | 48 | 0.040 |
Why?
|
| Keloid | 1 | 1998 | 11 | 0.040 |
Why?
|
| Mycophenolic Acid | 1 | 2018 | 58 | 0.040 |
Why?
|
| Pyridones | 1 | 1998 | 130 | 0.030 |
Why?
|
| Hemorrhage | 1 | 2021 | 519 | 0.030 |
Why?
|
| Immunosuppressive Agents | 2 | 2018 | 677 | 0.030 |
Why?
|
| Laser Coagulation | 1 | 2018 | 129 | 0.030 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 1998 | 313 | 0.030 |
Why?
|
| Conjunctival Diseases | 1 | 1996 | 26 | 0.030 |
Why?
|
| Vasculitis | 1 | 1996 | 49 | 0.030 |
Why?
|
| Aged, 80 and over | 3 | 2018 | 7137 | 0.030 |
Why?
|
| Antifungal Agents | 1 | 2018 | 306 | 0.030 |
Why?
|
| Infant | 3 | 2007 | 13235 | 0.030 |
Why?
|
| Acute Disease | 1 | 2018 | 1182 | 0.030 |
Why?
|
| Skin Diseases | 1 | 1996 | 136 | 0.030 |
Why?
|
| Scleral Diseases | 1 | 2013 | 1 | 0.030 |
Why?
|
| Muscle Neoplasms | 1 | 2013 | 21 | 0.030 |
Why?
|
| Tomography, Optical Coherence | 1 | 2018 | 573 | 0.020 |
Why?
|
| Injections, Intraocular | 1 | 2012 | 10 | 0.020 |
Why?
|
| Eye Pain | 1 | 2012 | 11 | 0.020 |
Why?
|
| Diplopia | 1 | 2012 | 38 | 0.020 |
Why?
|
| Oculomotor Muscles | 1 | 2012 | 68 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 2013 | 674 | 0.020 |
Why?
|
| Adult | 7 | 2009 | 31616 | 0.020 |
Why?
|
| Chromogranin A | 1 | 1990 | 4 | 0.020 |
Why?
|
| Synaptophysin | 1 | 1990 | 20 | 0.020 |
Why?
|
| Chromogranins | 1 | 1990 | 28 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 1 | 1990 | 252 | 0.020 |
Why?
|
| Aneuploidy | 1 | 1990 | 144 | 0.020 |
Why?
|
| Pigment Epithelium of Eye | 1 | 1989 | 36 | 0.020 |
Why?
|
| DNA, Neoplasm | 1 | 1990 | 301 | 0.020 |
Why?
|
| Serotonin | 1 | 1990 | 222 | 0.020 |
Why?
|
| Rabbits | 2 | 2000 | 709 | 0.020 |
Why?
|
| Ethoxzolamide | 1 | 1988 | 2 | 0.020 |
Why?
|
| Aqueous Humor | 1 | 1988 | 28 | 0.020 |
Why?
|
| Necrosis | 1 | 2009 | 210 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 1999 | 4754 | 0.020 |
Why?
|
| Child | 4 | 2023 | 25847 | 0.020 |
Why?
|
| Carbonic Anhydrase Inhibitors | 1 | 1988 | 29 | 0.020 |
Why?
|
| Thiazoles | 1 | 1988 | 104 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 1990 | 814 | 0.020 |
Why?
|
| Retinal Diseases | 1 | 1989 | 180 | 0.020 |
Why?
|
| Conjunctiva | 2 | 1999 | 187 | 0.020 |
Why?
|
| Young Adult | 1 | 2018 | 9921 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2018 | 13094 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 1990 | 1608 | 0.010 |
Why?
|
| Cattle | 1 | 2003 | 587 | 0.010 |
Why?
|
| Retrospective Studies | 3 | 2009 | 17526 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 2004 | 1163 | 0.010 |
Why?
|
| Prognosis | 1 | 1990 | 5032 | 0.010 |
Why?
|
| Virulence | 1 | 2000 | 278 | 0.010 |
Why?
|
| Triamcinolone Acetonide | 1 | 1999 | 36 | 0.010 |
Why?
|
| Electrophoresis, Cellulose Acetate | 1 | 1998 | 3 | 0.010 |
Why?
|
| Glycosaminoglycans | 1 | 1998 | 34 | 0.010 |
Why?
|
| Cell Transplantation | 1 | 1998 | 44 | 0.010 |
Why?
|
| Animals | 4 | 2003 | 36184 | 0.010 |
Why?
|
| Time Factors | 1 | 2009 | 6541 | 0.010 |
Why?
|
| Mice, Nude | 1 | 1998 | 780 | 0.010 |
Why?
|
| Child, Preschool | 3 | 2003 | 14865 | 0.010 |
Why?
|
| Prednisone | 1 | 1996 | 255 | 0.010 |
Why?
|
| Body Weight | 1 | 1998 | 1035 | 0.010 |
Why?
|
| Risk Factors | 1 | 2009 | 10935 | 0.010 |
Why?
|
| Cyclophosphamide | 1 | 1996 | 426 | 0.010 |
Why?
|
| Anti-Inflammatory Agents | 1 | 1996 | 314 | 0.010 |
Why?
|
| Skull | 1 | 1994 | 145 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2004 | 2575 | 0.010 |
Why?
|
| Benzothiazoles | 1 | 1988 | 31 | 0.000 |
Why?
|
| Conjunctivitis | 1 | 1988 | 20 | 0.000 |
Why?
|
| Permeability | 1 | 1988 | 131 | 0.000 |
Why?
|
| Reference Values | 1 | 1988 | 724 | 0.000 |
Why?
|
| Circadian Rhythm | 1 | 1988 | 298 | 0.000 |
Why?
|
| Adolescent | 1 | 2003 | 20549 | 0.000 |
Why?
|
| Mice | 1 | 1998 | 18928 | 0.000 |
Why?
|